Patent ID: 9394260
Filing Date: 2016-07-19
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A compound of Formula (II): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein: ring A is independently selected from the group consisting of: C X L is independently a hydrocarbon linker substituted with 0-2 R R and —(CH 2 ) n —(C 3-10 carbocycle substituted with 0-3 R c ); R R R R R R R R R R R n is, independently at each occurrence, selected from 0, 1, 2, 3, and 4; and p is, independently at each occurrence, selected from 0, 1, and 2; provided that the following compound is excluded: